House bill HR679-119
Energy and Commerce Committee
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
• Last activity on Jan 23, 2025
• Introduced Jan 23, 2025
• By Rep. Harshbarger, Diana [R-TN-1]